| Gregory Johnson, MS, CCC-SLP | |
|
1705 Huntington Rd, St Charles, IL 60174-5715 | |
| (224) 715-5561 | |
| Not Available |
| Full Name | Gregory Johnson |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 1705 Huntington Rd, St Charles, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144532599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 242001585 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Johnson, MS, CCC-SLP 1705 Huntington Rd, St Charles, IL 60174-5715 Ph: (224) 715-5561 | Gregory Johnson, MS, CCC-SLP 1705 Huntington Rd, St Charles, IL 60174-5715 Ph: (224) 715-5561 |
News Archive
The Justice Department's Civil Rights Division today announced that it has filed a motion for immediate relief to protect individuals confined in seven state-run psychiatric hospitals in Georgia from the imminent and serious threat of harm to their lives, health and safety.
Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy designation to PKC412 (midostaurin). PKC412 (midostaurin) is an investigational treatment for adults with newly-diagnosed AML who are FLT3 mutation-positive, as detected by an FDA-approved test, and who are eligible to receive standard induction and consolidation chemotherapy.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
Many people have noticed that as soon as you start using a skin cream, you have to continue with it; if you stop lubricating, your skin becomes drier than when you started. And now there is research to confirm for the first time that normal skin can become drier from creams. Izabela Buraczewska presents these findings in the dissertation she is publicly defending at Uppsala University in Sweden on October 24.
A seven-state snapshot of enrollment by the Kaiser Family Foundation indicates that the overhaul has not significantly boosted competition. (Kaiser Health News is an editorially independent part of the Foundation.)
› Verified 8 days ago
Katie Goldstein, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1304 Ronzheimer Ave, St Charles, IL 60174 Phone: 331-228-4873 | |
Amanda Wallace, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40w310 Lafox Rd, Suite A1/b1, St Charles, IL 60175 Phone: 630-444-0077 | |
Ms. Julie E Bonhotal, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40w803 Willowbrook Dr, St Charles, IL 60175 Phone: 815-404-9475 | |
Alicia Hizel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1601 E Main St, St Charles, IL 60174 Phone: 630-461-5931 | |
Mrs. Jamie Lynn Strock, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1304 Ronzheimer Ave, St Charles, IL 60174 Phone: 630-228-4873 | |
Kathleen A Altersohn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40w310 Lafox Rd, Ste 1a-b, St Charles, IL 60175 Phone: 630-444-0077 |